Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1533743 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.03Day −33.44%Mkt cap $6M1Y −63.1%Off 52W high −85.8%Vol (1Y) 186.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,129 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.8% of sh out |
| Days to cover1.4d |
| 13F net flow (QoQ)+1.52% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$14.1M |
| ROE−373.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−29.5% |
| 1Y−63.1% |
| 3Y−99.1% |
| 5Y−99.9% |
| 10Y−100.0% |
| Since incept. (ann.)−55.0% |
Price return through 2026-07-29 · series begins 2013-11-21. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)186.4% |
| Ann. volatility (3Y)179.3% |
| Sharpe (1Y)0.22 |
| Sharpe (3Y)−0.12 |
| Max drawdown (1Y)−84.6% |
| Max drawdown (3Y)−99.6% |
| Beta (3Y vs SPY)2.33 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Connective Capital Management, LLC | 70,736 | $178,608 | 2.57% | new |
| Stonepine Capital Management, LLC | 55,000 | $138,875 | 2.00% | +346.3% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,908 | $62,768 | 0.91% | +62.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 12,729 | $32,077 | 0.46% | new |
| VANGUARD FIDUCIARY TRUST CO | 10,857 | $27,360 | 0.39% | new |
| UBS Group AG | 2,531 | $6,391 | 0.09% | −80.0% |
| Tower Research Capital LLC (TRC) | 918 | $2,318 | 0.03% | −34.0% |
| CITIGROUP INC | 14 | $35 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$1.29 | — | — | — |
| 2025-09-30 | 2025-11-06 | — | — | — | — |
| 2025-06-30 | 2025-08-07 | — | — | — | — |
| 2025-03-31 | 2025-05-08 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
